Skip to product information
1 of 1

Merck Animal Health

Bovilis Guardian

Bovilis Guardian

Regular price $49.45 USD
Regular price Sale price $49.45 USD
Sale Sold out
Size

Guardian® vaccine is a multiple antigen product which includes a cell-free extract of K99 pilus type of Escherichia coli, a unique combination of two inactivated coronaviruses, two G-types of inactivated rotaviruses and a bacterin-toxoid from Clostridium perfringens Types C and D. It is recommended for use in healthy pregnant heifers and cows as an aid in the prevention of neonatal calf diarrhea caused by enterotoxigenic E. coli pilus type K99, bovine Group A Serotype G6 rotaviruses, enterotoxemia caused by C. perfringens Types C and D, and as an aid in the control of neonatal calf diarrhea caused by bovine coronaviruses.

BOVILIS GUARDIAN offers the broadest spectrum of antigens associated with major bacterial and viral causes of scours in young calves including rotavirus types G6 & G10, coronavirus types 1 & 3, Clostridium perfringens types C & D, and Escherichia coli type K99.

Manufacturer and/or Label Information

MERCK ANIMAL HEALTH
Intervet Inc.
2 GIRALDA FARMS, MADISON, NJ, 07940
Customer Service: 800-521-5767
Order Desk: 800-648-2118
Technical Service (Companion Animal): 800-224-5318
Technical Service (Livestock): 800-211-3573
Fax: 973-937-5557
Website: www.merck-animal-health-usa.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
BOVILIS® Guardian®

Intervet/Merck Animal Health

Bovine Rotavirus-Coronavirus Vaccine

Killed Virus, Clostridium Perfringens Types C & D-Escherichia Coli Bacterin-Toxoid

This product has been shown to be effective for the vaccination of healthy pregnant cattle to provide passive immunity against neonatal calf diarrhea due to bovine Group A Serotype G6 rotaviruses, enterotoxigenic E. coli pilus type K99, and bovine coronavirus, and enterotoxemia due to C. perfringens Types C & D in calves. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

DOSAGE: Shake well and administer a single 2.0 mL vaccination dose by subcutaneous route to pregnant cattle 3 months prior to calving and a single 2.0 mL booster dose 3 - 6 weeks following initial vaccination. For subsequent calvings, revaccinate with a single 2.0 mL dose 5 - 7 weeks prior to calving.

CAUTION: Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened. Do not mix with other products. Do not vaccinate within 60 days before slaughter. Transient local reaction may occur at the injection site. Anaphylactoid reactions may occur following use. Antidote: Epinephrine. Contains gentamicin and thimerosal as preservatives. In case of human exposure, contact a physician.

FOR ANIMAL USE ONLY

Intervet Inc., d/b/a Merck Animal Health, Omaha, NE 68103 USA

VLN 165A/ PCN 4575.20 / 1-800-521-5767

For Patent info.: http://www.merck.com/product/patent/home.html







Code



20 mL

10 Doses

2 mL per dose

065302

399744-17

100 mL

50 Doses

065307

373725-17

CPN: 1047566.0



COLORADO SERUM COMPANY4950 YORK STREET, P.O. BOX 16428, DENVER, CO, 80216-0428Telephone: 303-295-7527Order Desk: 800-525-2065Fax: 303-295-1923Website: www.colorado-serum.comEmail: colorado-serum@colorado-serum.comTHIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

TETANUS TOXOID-CONCENTRATED

Colorado Serum

Adjuvanted

GENERAL INFORMATION: This product has been shown to be effective for the vaccination of healthy horses, cattle, sheep, goats, and swine against tetanus. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Safety in pregnant animals is unknown.

Tetanus Toxoid is prepared by detoxifying tetanus toxin in such a manner as to allow the antigenic properties to remain intact. Product is purified, concentrated and adjuvanted to provide a low dose effective immunizing agent.

Each serial is tested for purity, safety, and potency in accordance with USDA requirements.

Tetanus is caused by a neurotoxin produced by growth of Clostridium tetani, an anaerobic (lives without air) micro-organism, in necrotic tissue. Affected animals become stiff, have difficulty swallowing, and have an increased pulse rate. Breathing is labored. Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw.

Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw. Thus, the term “lockjaw” is often used. Legs and tail are often stiff with abdominal muscles contracted. Tetanus stricken animals may be unusually sensitive to light and heat. Temperature of the animal generally remains normal, elevating only shortly before death.

Protective antibody levels usually occur about two weeks after the second injection of the primary immunization series. In contrast, administration of Tetanus Antitoxin is recommended for immediate, emergency, passive treatment of exposed animals with unknown vaccination history or with signs of tetanus infection.

DIRECTIONS: Do not vaccinate within 21 days before slaughter. Store at 2-8° C. Do not freeze. Do not mix with other products. Shake well before use. Use entire contents when first opened.

PRECAUTIONS: A transitory local reaction may occur at injection site. Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent. In case of human exposure, consult a physician.

DOSAGE & ADMINISTRATION: For primary immunization, two doses should be administered subcutaneously or intramuscularly approximately 30 days apart. Use intramuscularly for horses as local reactions are more likely to occur if injected subcutaneously.

Horses: 1 ml IM

Cattle: 1 ml SC or IM

Sheep, Goats, Swine: 0.5 ml SC or IM

Historically, annual single dose revaccination has been recommended. Contact veterinarian for advice.

OTHER INFORMATION: Contains thimerosal and formalin as preservatives. Tetanus Toxoid Concentrate is available in single dose size packaged 10 vials to the carton, and in 10 dose vials.

THE PEAK OF QUALITY SINCE 1923

VLN: 188 / PCN: 8601.00

COLORADO SERUM COMPANY, 4950 York Street, Denver, Colorado 80216

303-295-752

www.colorado-serum.com

Contact us for information on other Colorado Serum Company products. Fine Veterinary Products since 1923.

FOR VETERINARY USE ONLY

 

 

Order #

10 - 1 ml vials

10 - 1 dose vials

11411

10 ml

10 doses

11415

CPN: 1101033.3

Dimensions

Care information

View full details